Dr. Anthony Iluyomade, MD

Dr. Iluyomade practices at Northside Hospital Forsyth in Cumming, Georgia, part of Northside Hospital.

Dr. Iluyomade's NPI, 1437554250, was assigned on October 23, 2014. Dr. Iluyomade holds Georgia license 80455.

Dr. Iluyomade's primary practice is Northside Hospital Forsyth, at 1200 Northside Forsyth Drive, Cumming, GA 30041 in Forsyth County. The practice phone is (770) 844-3200.

Dr. Iluyomade's primary practice is Northside Hospital Forsyth in Cumming, Georgia, part of Northside Hospital. Dr. Iluyomade is also affiliated with Northside Hospital Cherokee. The medical group on file is Northeast Georgia Physicians Group Inpatient Neurology. Dmand AI also links Dr. Iluyomade to 1 more hospital, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iluyomade practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Iluyomade's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Iluyomade's licenses on file in 2 states: Georgia and California.

CMS data shows 812 Medicare services from Dr. Iluyomade across 6 procedure codes in 2024, for 321 Medicare patients. Medicare paid $54,601 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 321 Medicare patients who saw Dr. Iluyomade in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iluyomade's median patient age at 72, with 56% women.

In 2024, Dr. Iluyomade wrote 314 Medicare Part D claims for 131 patients. 87% of them were for generic drugs. CMS names the drug for 93 of them, across 7 drugs with 11 or more claims each, at $5,941 in total drug cost. In 2023, CMS named 166 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Iluyomade for performance year 2024, reported as part of a group. Dr. Iluyomade accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Iluyomade in 2015. Dr. Iluyomade's most frequent co-authors are Anthony A. Donato, MD, Opeyemi Fadahunsi, MD and Abiola Olowoyeye.

CMS Open Payments shows 12 general payments to Dr. Iluyomade from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 97% of the total. Lumenis BE inc paid the most, $2,767.